Berrin Tunca

1.8k total citations
113 papers, 1.3k citations indexed

About

Berrin Tunca is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Berrin Tunca has authored 113 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 40 papers in Cancer Research and 31 papers in Oncology. Recurrent topics in Berrin Tunca's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (16 papers) and DNA Repair Mechanisms (12 papers). Berrin Tunca is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (16 papers) and DNA Repair Mechanisms (12 papers). Berrin Tunca collaborates with scholars based in Türkiye, Russia and United States. Berrin Tunca's co-authors include Ünal Egelí, Gülşah Çeçener, Gamze Güney Eskiler, Gülçin Tezcan, Seçil Ak, Şahsine Tolunay, Ahmet Bekâr, Ömer Yerci, İsmet Taşdelen and Seçil Ak Aksoy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Health Perspectives and Annals of Oncology.

In The Last Decade

Berrin Tunca

112 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berrin Tunca Türkiye 20 719 453 229 171 106 113 1.3k
Ünal Egelí Türkiye 20 759 1.1× 475 1.0× 254 1.1× 241 1.4× 97 0.9× 124 1.4k
Gülşah Çeçener Türkiye 19 630 0.9× 372 0.8× 214 0.9× 131 0.8× 109 1.0× 108 1.1k
Peng Bai China 24 972 1.4× 380 0.8× 192 0.8× 92 0.5× 74 0.7× 69 1.5k
Jialing Zhang China 21 763 1.1× 349 0.8× 220 1.0× 88 0.5× 85 0.8× 65 1.4k
Jingliang Cheng China 22 779 1.1× 231 0.5× 236 1.0× 196 1.1× 44 0.4× 110 1.5k
Sandrine Dabernat France 22 1.2k 1.7× 312 0.7× 389 1.7× 223 1.3× 56 0.5× 55 1.7k
Yi Lü United States 23 933 1.3× 260 0.6× 349 1.5× 305 1.8× 54 0.5× 68 1.6k
Mei Zhang China 18 649 0.9× 299 0.7× 275 1.2× 86 0.5× 76 0.7× 56 1.2k
Yuanyuan Wu China 21 1.1k 1.6× 674 1.5× 129 0.6× 95 0.6× 42 0.4× 52 1.5k
Custodia García‐Jiménez Spain 17 860 1.2× 285 0.6× 244 1.1× 106 0.6× 28 0.3× 37 1.3k

Countries citing papers authored by Berrin Tunca

Since Specialization
Citations

This map shows the geographic impact of Berrin Tunca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berrin Tunca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berrin Tunca more than expected).

Fields of papers citing papers by Berrin Tunca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berrin Tunca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berrin Tunca. The network helps show where Berrin Tunca may publish in the future.

Co-authorship network of co-authors of Berrin Tunca

This figure shows the co-authorship network connecting the top 25 collaborators of Berrin Tunca. A scholar is included among the top collaborators of Berrin Tunca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berrin Tunca. Berrin Tunca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ocak, Pınar Eser, Gülçin Tezcan, Fatma Nur Parın, et al.. (2024). A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiber. Asian Journal of Pharmaceutical Sciences. 19(6). 100971–100971. 1 indexed citations
2.
3.
Tezcan, Gülçin, Seçil Ak Aksoy, Hasan Kocaelı, et al.. (2023). Concurrent presence of diabetes affects the GLUT3 programming of glucose metabolism in glioblastoma.. PubMed. 27(17). 8110–8118. 1 indexed citations
4.
Taşkapılıoğlu, Özlem, Gülşah Çeçener, Ünal Egelí, et al.. (2023). Investigation of miR-146a Expression Profiles in Fecal Samples of Patients With Multiple Sclerosis for Early Diagnosis and Treatment. SHILAP Revista de lepidopterología. 40(2). 81–87. 3 indexed citations
5.
6.
Çeçener, Gülşah, et al.. (2021). Investigation of VHL gene associated with miR-223 in clear cell renal cell carcinoma. Molecular Biology Reports. 49(3). 2073–2083. 1 indexed citations
7.
Egelí, Ünal, et al.. (2021). The Anticancer Effect of Inula viscosa Methanol Extract by miRNAs’ Re-regulation: An in vitro Study on Human Malignant Melanoma Cells. Nutrition and Cancer. 74(1). 211–224. 10 indexed citations
8.
Aksoy, Seçil Ak, Gülçin Tezcan, Berrin Tunca, et al.. (2021). DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer. Genetic Testing and Molecular Biomarkers. 25(4). 276–283. 2 indexed citations
9.
Eskiler, Gamze Güney, Gülşah Çeçener, Ünal Egelí, & Berrin Tunca. (2020). Talazoparib nanoparticles for overcoming multidrug resistance in triple‐negative breast cancer. Journal of Cellular Physiology. 235(9). 6230–6245. 23 indexed citations
10.
Tezcan, Gülçin, Berrin Tunca, Ahmet Bekâr, et al.. (2019). Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract. Human & Experimental Toxicology. 38(9). 1102–1110. 15 indexed citations
11.
Eskiler, Gamze Güney, Gülşah Çeçener, Ünal Egelí, & Berrin Tunca. (2019). Reversal effect of quercetin on talazoparib resistance in BRCA1 mutant triple negative breast cancer. The European Research Journal. 6(1). 19–25. 2 indexed citations
12.
Eskiler, Gamze Güney, et al.. (2019). Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor‐positive breast and prostate cancer cells. Journal of Biochemical and Molecular Toxicology. 33(8). e22338–e22338. 7 indexed citations
13.
Egelí, Ünal, et al.. (2018). The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. Human & Experimental Toxicology. 38(2). 201–215. 28 indexed citations
14.
Eskiler, Gamze Güney, et al.. (2018). In vitro cytotoxic and antiproliferative effects of usnic acid on hormone‐dependent breast and prostate cancer cells. Journal of Biochemical and Molecular Toxicology. 32(10). e22208–e22208. 19 indexed citations
15.
16.
Çetintaş, Sibel, et al.. (2018). Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study. Bosnian Journal of Basic Medical Sciences. 19(2). 172–179. 1 indexed citations
17.
Ak, Seçil, Gamze Güney Eskiler, Elif Ertürk, et al.. (2016). Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.. PubMed. 17(9). 4241–4246. 23 indexed citations
18.
Eskiler, Gamze Güney, Gülşah Çeçener, Berrin Tunca, & Ünal Egelí. (2016). An in vitro model for the development of acquired tamoxifen resistance. Cell Biology and Toxicology. 32(6). 563–581. 12 indexed citations
19.
Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.. PubMed. 98(2). 243–51. 11 indexed citations
20.
Tunca, Berrin & Ünal Egelí. (1996). Cytogenetic findings on shoe workers exposed long-term to benzene.. Environmental Health Perspectives. 104(suppl 6). 1313–1317. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ünal Egelí Breakdown of academic impact, for papers by Gülşah Çeçener Breakdown of academic impact, for papers by Peng Bai Breakdown of academic impact, for papers by Jialing Zhang Breakdown of academic impact, for papers by Jingliang Cheng Breakdown of academic impact, for papers by Sandrine Dabernat Breakdown of academic impact, for papers by Yi Lü Breakdown of academic impact, for papers by Mei Zhang Breakdown of academic impact, for papers by Yuanyuan Wu Breakdown of academic impact, for papers by Custodia García‐Jiménez
Rankless by CCL
2026